• For Institutions

    • Corporate Services
    • Developers
  • Download
  • Help
  • About

    • Company Profile
    • License & Regulatory
    • Media coverage
longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
All
Options & Futures
Funds
IPO Subscription
Structured Products
Investment Wiki
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List

Illumina(ILMN.US)

Overview
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Dec27
Pacer Advisors Inc. Increased Holdings in Illumina Inc. in Q3
11:14
Dec21
Illumina and MyOme Collaborate on Combining Whole Genome Sequencing with AI Risk Models
18:22
Dec17
Jefferies, JPMorgan, and Barclays Issue Ratings for Illumina Stock
10:42
Illumina's Chief Legal Officer Sells Shares
03:47
Dec15
JPMorgan Raises Illumina's Target Price to $130
09:43
Dec14
Illumina and MyOme Partner to Advance Genomic Sequencing with AI
15:38

Schedules & Filings

Schedules
Filings
Oct30
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 1.084 B, Net Income 150 M, EPS 0.98

Illumina, Inc. (ILMN.US) Q3 2025 Earnings Conference CallIllumina, Inc. (ILMN.US) Q3 2025 Earnings Conference Call
Jul31
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 1.059 B, Net Income 235 M, EPS 1.49

May8
Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 1.041 B, Net Income 131 M, EPS 0.82

Illumina, Inc. (ILMN.US) Q1 2025 Earnings Conference CallIllumina, Inc. (ILMN.US) Q1 2025 Earnings Conference Call
View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
INBS
11.526
+181.11%
+7.460
ANGH
3.895
+67.89%
+1.575
ESHA
22.044
+53.29%
+7.664
NCL
0.2855
+47.16%
+0.091
ESHAR
0.2500
+47.06%
+0.080
SIDU
3.585
+34.27%
+0.915
RDACR
0.2493
+31.21%
+0.059
ORIS
1.550
+27.05%
+0.330
ULY
3.500
+26.81%
+0.740
VNDA
8.911
+26.75%
+1.885
View More